LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: The Relevance of Aurora Kinase Inhibition in Hematological Malignancies.

    Machado, Caio Bezerra / DA Silva, Emerson Lucena / Dias Nogueira, Beatriz Maria / DA Silva, Jean Breno Silveira / DE Moraes Filho, Manoel Odorico / Montenegro, Raquel Carvalho / DE Moraes, Maria Elisabete Amaral / Moreira-Nunes, Caroline Aquino

    Cancer diagnosis & prognosis

    2021  Volume 1, Issue 3, Page(s) 111–126

    Abstract: Aurora kinases are a family of serine/threonine protein kinases that play a central role in eukaryotic cell division. Overexpression of aurora kinases in cancer and their role as major regulators of the cell cycle quickly inspired the idea that their ... ...

    Abstract Aurora kinases are a family of serine/threonine protein kinases that play a central role in eukaryotic cell division. Overexpression of aurora kinases in cancer and their role as major regulators of the cell cycle quickly inspired the idea that their inhibition might be a potential pathway when treating oncologic patients. Over the past couple of decades, the search for designing and testing of molecules capable of inhibiting aurora activities fueled many pre-clinical and clinical studies. In this study, data from the past 10 years of in vitro and in vivo investigations, as well as clinical trials, utilizing aurora kinase inhibitors as therapeutics for hematological malignancies were compiled and discussed, aiming to highlight potential uses of these inhibitors as a novel monotherapy model or alongside conventional chemotherapies. While there is still much to be elucidated, it is clear that these kinases play a key role in oncogenesis, and their manageable toxicity and potentially synergistic effects still render them a focus of interest for future investigations in combinatorial clinical trials.
    Language English
    Publishing date 2021-07-03
    Publishing country Greece
    Document type Journal Article ; Review
    ISSN 2732-7787
    ISSN (online) 2732-7787
    DOI 10.21873/cdp.10016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Post-COVID-19 Cognitive Decline and Apoe Polymorphism: Towards a Possible Link?

    Tavares-Júnior, José Wagner Leonel / Oliveira, Danilo Nunes / da Silva, Jean Breno Silveira / Queiroz Feitosa, Werbety Lucas / Sousa, Artur Victor Menezes / Marinho, Samuel Cavalcante / Cunha, Letícia Chaves Vieira / Gaspar, Safira de Brito / Gomes, Carmem Meyve Pereira / de Oliveira, Laís Lacerda Brasil / Moreira-Nunes, Caroline Aquino / Sobreira, Emmanuelle Silva Tavares / Moraes, Maria Elisabete Amaral de / Sobreira-Neto, Manoel Alves / Montenegro, Raquel Carvalho / Braga-Neto, Pedro

    Brain sciences

    2023  Volume 13, Issue 12

    Abstract: ... ...

    Abstract APOE
    Language English
    Publishing date 2023-11-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2651993-8
    ISSN 2076-3425
    ISSN 2076-3425
    DOI 10.3390/brainsci13121611
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Long-covid cognitive impairment: Cognitive assessment and apolipoprotein E (APOE) genotyping correlation in a Brazilian cohort.

    Tavares-Júnior, José Wagner Leonel / Oliveira, Danilo Nunes / da Silva, Jean Breno Silveira / Feitosa, Werbety Lucas Queiroz / Sousa, Artur Victor Menezes / Cunha, Letícia Chaves Vieira / Gaspar, Safira de Brito / Gomes, Carmem Meyve Pereira / de Oliveira, Laís Lacerda Brasil / Moreira-Nunes, Caroline Aquino / Montenegro, Raquel Carvalho / Sobreira-Neto, Manoel Alves / Braga-Neto, Pedro

    Frontiers in psychiatry

    2022  Volume 13, Page(s) 947583

    Abstract: Introduction: Few studies have objectively evaluated cognitive deficits after the acute phase of COVID-19 disease. Moreover, the role of apolipoprotein E (APOE) genotypes in cognitive decline in patients with COVID-19 has not been evaluated yet.: ... ...

    Abstract Introduction: Few studies have objectively evaluated cognitive deficits after the acute phase of COVID-19 disease. Moreover, the role of apolipoprotein E (APOE) genotypes in cognitive decline in patients with COVID-19 has not been evaluated yet.
    Methods: This cross-sectional study was conducted in confirmed cases of COVID-19 patients with neurological symptoms that persisted for more than 3 months from the onset. We determined APOE genotypes.
    Results: The final sample consisted of 141 patients. The most frequent APOE genotype was E3/E3 (
    Discussion: Hospitalized patients had more severe infection with a greater possibility of systemic complications, greater inflammatory response, and prolonged hospitalization, which could impact cognitive performance. Cognitive impairment in patients with COVID-19 does not necessarily involve specific APOE polymorphisms. However, psychiatric disorders may also be responsible for cognitive complaints. Cognitive complaints are frequent in patients with COVID-19, even after the acute phase of the disease and in mild cases. Hospitalized participants and depressed patients may have a higher risk of cognitive impairment. APOE genotypes or haplotypes may not significantly play a role in COVID-19 cognitive impairment.
    Language English
    Publishing date 2022-08-10
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2564218-2
    ISSN 1664-0640
    ISSN 1664-0640
    DOI 10.3389/fpsyt.2022.947583
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top